or
forgot password

Optimizing Influenza Vaccination in Surgical Oncology Patients


Phase 4
18 Years
N/A
Open (Enrolling)
Both
Influenza

Thank you

Trial Information

Optimizing Influenza Vaccination in Surgical Oncology Patients


Inclusion Criteria:

Patients with gastric or pancreatic cancer, soft tissue sarcoma or
peritoneal surface malignancy who will undergo surgery with curative intent are eligible.

-

Exclusion Criteria:Those with a contraindication to vaccination, patients who have a
splenectomy (whether planned or not) and those who have had the flu for the year are not
eligible.

-

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Outcome Measure:

Antibody Titer

Outcome Description:

Serum antibody titers will be assessed prior to vaccination.

Outcome Time Frame:

Baseline

Safety Issue:

No

Principal Investigator

Colette R Pameijer, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stony Brook University

Authority:

United States: Institutional Review Board

Study ID:

240293

NCT ID:

NCT01698177

Start Date:

October 2011

Completion Date:

July 2013

Related Keywords:

  • Influenza
  • Influenza
  • Cancer
  • Vaccination
  • Immune response to influenza vaccination
  • Influenza, Human

Name

Location
Stony Brook Hospital Stony Brook, New York  11794